David Shaw, founder of the wildly successful D.E. Shaw hedge fund, has made some risky moves in the last quarter, according to just-released 13F forms filed with the SEC. He revealed a bullish sentiment on controversial healthcare stock Valeant Pharmaceuticals International, Inc. (NYSE:VRX) and MannKind Corporation (NASDAQ:MNKD).
Computer science professor David Shaw founded one of the first…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.